908 Devices Inc. (MASS) Stock

908 Devices Inc. (MASS) is a Technology stock trading at $10.32 (as of 2026-08-20), with a market capitalization of $426.56M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

908 Devices Inc. develops purpose-built handheld and desktop mass spectrometry instruments and related platforms, including the MX908 analyzer, the Rebel desktop system for monitoring extracellular bioprocess conditions, and ZipChip for plug-and-play high-resolution separation. Its products are used in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets across the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Understand 908 Devices Inc.: how it makes money

908 Devices Inc. provides handheld and desktop mass spectrometry (Mass Spec) instruments, including MX908, Rebel, and ZipChip, and generates revenue from product and service offerings.

The business shows positive gross margin (51.4%), but a very large operating loss (operating margin of -96.3%), while the provided indicators for recurring revenue related to handhelds and desktops are 0.0, so profitability likely depends on scaling device sales and converting the installed base into monetization beyond initial device shipments.

Business quality (Weak): Early-stage profile: hardware-driven activity is measurable via installed base and shipments, but the company is not showing operating profitability, and recurring revenue indicators are currently at 0.0.

Bull case

Installed base and shipment activity are tracked: The company reports a cumulative handheld and desktop device installed base of 3,903 (count) and devices shipped of 167 (count), showing ongoing deployments of its Mass Spec devices.
Multiple product lines are represented in revenue: Revenue categories shown include Product and Service Revenue (0.02B), MX-908 Handheld Device Revenue (0.01B), and Desktop Product Revenue (0.01B), consistent with a diversified offering across handheld and desktop analyzers.

Bear case

Operating losses are very large versus gross margin: In the latest reported period, operating margin is -96.3% despite gross margin of 51.4%, indicating that operating expenses overwhelm gross profit.
Recurring revenue signals are currently zero in the provided data: The provided operational KPIs list recurring revenue related to handhelds as 0.0B and recurring revenue related to desktops as 0.0B, which can make future profitability harder if repeat sales do not translate into ongoing revenue.

Valuation — source: SEC EDGAR (first-party)
Price	$10.32
Market Cap	$426.56M
Price / Book	3.36
Price / Sales	7.50
FCF Yield	-4.6%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$56.20M
Net Margin	34.7%
Revenue Growth (YoY)	-5.8%
EPS Growth (YoY)	-125.5%
FCF Growth (YoY)	-20.1%

Financial Health — source: SEC EDGAR
Altman Z-Score	3.66 (safe)

Valuation vs Sector & Industry
Sector P/E (Technology)	33.9
Industry P/E (Measuring & Control Equipment)	51.8

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	First Light Asset Management, LLC ($37.16M)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Measuring & Control Equipment
CEO	Kevin J. Knopp
Employees	246
Country	US
IPO Date	2020-12-18

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.